(Q51600138)
Statements
Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen. (English)
1 reference
Aguilar JC
1 reference
Lobaina Y
1 reference
Muzio V
1 reference
García D
1 reference
Pentón E
1 reference
Iglesias E
1 reference
Pichardo D
1 reference
Urquiza D
1 reference
Rodríguez D
1 reference
Silva D
1 reference
Guillén G
1 reference
1 October 2004
1 reference
82
1 reference
5
1 reference
539-546
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference